+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Association between left ventricular hypertrophy and erythrocyte sodium-lithium exchange in normotensive subjects with and without NIDDM



Association between left ventricular hypertrophy and erythrocyte sodium-lithium exchange in normotensive subjects with and without NIDDM



Diabetologia. 38(4): 454-460



The determinants of left ventricular mass in normal control subjects and subjects with non-insulin-dependent diabetes (NIDDM) are ill-defined. We therefore recorded M-mode and pulsed Doppler echocardiograms and 24-h ambulatory blood pressure in 57 normotensive subjects, 34 with NIDDM and 23 matched non-diabetic control subjects. Measurements of erythrocyte sodium-lithium countertransport, plasma angiotensin II, plasma and platelet catecholamines and fasting plasma insulin were also made. Six control subjects (26%) and 15 diabetic subjects (44%) had some degree of left ventricular hypertrophy. Subjects with left ventricular hypertrophy (n = 21) had an elevated mean rate of sodium-lithium countertransport (0.40 +- 0.13 vs 0.31 +- 0.09 mmol cntdot l-1 cntdot h-1; p lt 0.01), parallel differences being observed in both the diabetic and control groups. Twelve of the subjects with left ventricular hypertrophy (57%) had elevated rates of sodium-lithium countertransport compared to only seven (19%) of those without (p lt 0.05). There was no consistent difference between those with and without left ventricular hypertrophy in any other clinical or biochemical variable. Multivariate analysis, with the presence or absence of left ventricular hypertrophy as the dependent variable, demonstrated that the maximal rate of sodium-lithium countertransport was the only variable that independently contributed to left ventricular hypertrophy (partial r = 0.35; F-1.55 = 7.74; p = 0.007). This study demonstrates for the first time an association between left ventricular hypertrophy and erythrocyte membrane cation transport that is independent of hypertension. is present in both diabetic and non-diabetic groups, and may represent a link between elevated rates of membrane sodium transport and cardiovascular risk.

(PDF emailed within 0-6 h: $19.90)

Accession: 008196130

Download citation: RISBibTeXText

PMID: 7796986

DOI: 10.1007/bf00410283


Related references

Exaggerated blood pressure response to exercise association with left ventricular hypertrophy in normotensive subjects. American Heart Association Monograph (124): II-73, 1986

Sodium-lithium transport and left ventricular hypertrophy in normotensive type 2 diabetics and non-diabetics. Diabetologia 36(SUPPL 1): A7, 1993

Impact of Ramipril on left ventricular hypertrophy in normotensive non-albuminuric NIDDM patients. Diabetologia 40(SUPPL 1): A30, 1997

Beneficial Impact of Ramipril on Left Ventricular Hypertrophy in Normotensive Nonalbummuric Niddm Patients. Diabetes Care 21(5): 804-809, 1998

Beneficial impact of ramipril on left ventricular hypertrophy in normotensive nonalbuminuric NIDDM patients. Diabetes Care 22(1): 178-179, 1999

Beneficial impact of ramipril on left ventricular hypertrophy in normotensive nonalbuminuric NIDDM patients. Diabetes Care 21(5): 804-809, 1998

Dysfunction of the erythrocyte sodium-lithium countertransporter in black normotensive subjects. Puschett, J B International Congress Series; Diuretics IV: Chemistry, pharmacology and clinical applications: 829-832, 1993

Erythrocyte sodium-lithium countertransport activity and retinol binding protein excretion in healthy normotensive subjects. Clinical Science 95(2): 5P, 1998

Erythrocyte Sodium-Lithium Countertransport (SLC) Activity and Retinol Binding Protein (Rbp) Excretion in Healthy Normotensive Subjects. Clinical Science 95(S39): 5p.2-5p, 1998

Kinetic characteristics of the erythrocyte sodium-lithium countertransporter in black normotensive subjects compared with three other ethnic groups. Journal of Human Hypertension 12(1): 29-34, 1998

Dietary sodium intake and left ventricular hypertrophy in normotensive rats. American Journal of Physiology 261(5 Pt 2): H1397-H1401, 1991

Urinary retinol-binding protein (RBP) excretion and erythrocyte sodium-lithium countertransport (SLC) activity in a cohort of healthy normotensive subjects. Journal of Human Hypertension 13(12): 871-873, 2000

Left ventricular hypertrophy and Fat Free Mass Role of muscle phenotype in obese normotensive subjects. International Journal of Obesity 26(Supplement 1): S180, 2002

Left ventricular hypertrophy regression Role of weight loss and insulin changes in obese normotensive subjects. International Journal of Obesity 25(Supplement 2): S74-S75, 2001

Relationship between maximum arterial pressure response to exercise and left ventricular hypertrophy in normotensive subjects. Revista Espanola de Cardiologia 47(8): 529-535, 1994